BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27713887)

  • 1. New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure.
    Valenzuela-Sánchez F; Valenzuela-Méndez B; Rodríguez-Gutiérrez JF; Estella-García Á; González-García MÁ
    Ann Transl Med; 2016 Sep; 4(17):329. PubMed ID: 27713887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of procalcitonin and mid-regional pro-adrenomedullin in septic paediatric patients.
    Solé-Ribalta A; Bobillo-Pérez S; Valls A; Girona-Alarcón M; Launes C; Cambra FJ; Jordan I; Esteban E
    Eur J Pediatr; 2020 Jul; 179(7):1089-1096. PubMed ID: 31974673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?
    Spoto S; Basili S; Cangemi R; D'Avanzo G; Lupoi DM; Romiti GF; Argemi J; Yuste JR; Lucena F; Locorriere L; Masini F; Testorio G; Calarco R; Fogolari M; Francesconi M; Battifoglia G; Costantino S; Angeletti S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.
    Christ-Crain M; Morgenthaler NG; Struck J; Harbarth S; Bergmann A; Müller B
    Crit Care; 2005; 9(6):R816-24. PubMed ID: 16356231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR- proADM to detect specific types of organ failure in infection.
    Andrés C; Andaluz-Ojeda D; Cicuendez R; Nogales L; Martín S; Martin-Fernandez M; Almansa R; Calvo D; Esteban-Velasco MC; Vaquero-Roncero LM; Ríos-Llorente A; Sanchez-Barrado E; Muñoz-Bellvís L; Aldecoa C; Bermejo-Martin JF
    Eur J Clin Invest; 2020 Jun; 50(6):e13246. PubMed ID: 32307701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
    Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
    Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
    Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
    APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of mid-regional pro-adrenomedullin in sepsis are associated with risk of death.
    Valenzuela-Sánchez F; Valenzuela-Méndez B; Bohollo de Austria R; Rodríguez-Gutiérrez JF; Estella-García Á; Fernández-Ruiz L; González-García MÁ; Rello J
    Minerva Anestesiol; 2019 Apr; 85(4):366-375. PubMed ID: 30207133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
    Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
    Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
    Travaglino F; De Berardinis B; Magrini L; Bongiovanni C; Candelli M; Silveri NG; Legramante J; Galante A; Salerno G; Cardelli P; Di Somma S
    BMC Infect Dis; 2012 Aug; 12():184. PubMed ID: 22874067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study.
    Viaggi B; Poole D; Tujjar O; Marchiani S; Ognibene A; Finazzi S
    PLoS One; 2018; 13(8):e0201491. PubMed ID: 30102716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients.
    Lundberg OH; Bergenzaun L; Rydén J; Rosenqvist M; Melander O; Chew MS
    Crit Care; 2016 Jun; 20(1):178. PubMed ID: 27282767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
    Bernal-Morell E; García-Villalba E; Vera MDC; Medina B; Martinez M; Callejo V; Valero S; Cinesi C; Piñera P; Alcaraz A; Marin I; Muñoz A; Cano A
    J Infect; 2018 Mar; 76(3):249-257. PubMed ID: 29246637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.
    Montrucchio G; Sales G; Balzani E; Lombardo D; Giaccone A; Cantù G; D'Antonio G; Rumbolo F; Corcione S; Simonetti U; Bonetto C; Zanierato M; Fanelli V; Filippini C; Mengozzi G; Brazzi L
    Front Med (Lausanne); 2023; 10():1122367. PubMed ID: 37035317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
    Montrucchio G; Sales G; Rumbolo F; Palmesino F; Fanelli V; Urbino R; Filippini C; Mengozzi G; Brazzi L
    PLoS One; 2021; 16(2):e0246771. PubMed ID: 33556140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis.
    Cander B; Visneci EF; Karaoglan O; Cakmak F; Tuncar A; Taslidere B
    Open Med (Wars); 2023; 18(1):20230865. PubMed ID: 38223899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department.
    Piccioni A; Saviano A; Cicchinelli S; Valletta F; Santoro MC; de Cunzo T; Zanza C; Longhitano Y; Tullo G; Tilli P; Candelli M; Covino M; Franceschi F
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin and MR-Proadrenomedullin Combination with SOFA and qSOFA Scores for Sepsis Diagnosis and Prognosis: A Diagnostic Algorithm.
    Spoto S; Cella E; de Cesaris M; Locorriere L; Mazzaroppi S; Nobile E; Lanotte AM; Pedicino L; Fogolari M; Costantino S; Dicuonzo G; Ciccozzi M; Angeletti S
    Shock; 2018 Jul; 50(1):44-52. PubMed ID: 29023361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review.
    Önal U; Valenzuela-Sánchez F; Vandana KE; Rello J
    Healthcare (Basel); 2018 Sep; 6(3):. PubMed ID: 30177659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock.
    Spoto S; Fogolari M; De Florio L; Minieri M; Vicino G; Legramante J; Lia MS; Terrinoni A; Caputo D; Costantino S; Bernardini S; Ciccozzi M; Angeletti S
    Microb Pathog; 2019 Dec; 137():103763. PubMed ID: 31574301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.